Identification of GPD1L as a Potential Prognosis Biomarker and Associated with Immune Infiltrates in Lung Adenocarcinoma

Table 3

Univariate and multivariate analysis of disease-specific survival in LUAD patients.

Characteristics	Total ()	Univariate analysis		Multivariate analysis
		Hazard ratio (95% CI)	value	Hazard ratio (95% CI)	value
Gender	491
Female	262	Reference
Male	229	0.989 (0.687-1.424)	0.954
Age	481
< =65	243	Reference
>65	238	1.013 (0.701-1.464)	0.944
Pathologic stage	483
Stage I and stage II	389	Reference
Stage III and stage IV	94	2.436 (1.645-3.605)	<0.001	2.269 (1.530-3.367)	<0.001
GPD1L	491
Low	241	Reference
High	250	0.517 (0.355-0.752)	<0.001	0.545 (0.373-0.798)	0.002